Kesimpta 20 MG/0.4 ML pen 0.4ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1W18
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $36,723
Award facts
- Contract value 100% obligated
- $36,723.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $36,723.25 delivery order to AmerisourceBergen Drug Corp (a subsidiary of parent company Cencora, Inc.) on January 20, 2026, for the supply of Kesimpta 20 mg/0.4 ml pen injectors. This competitive, firm fixed-price delivery order was placed without a set-aside designation and is scheduled for completion by January 21, 2026, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999.00 and running through December 2026, which enables the company to supply an extensive range of pharmaceuticals and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, as a major pharmaceutical distributor, routinely fulfills federal medical procurement needs through its DLA contract vehicle, supplying medications across multiple therapeutic domains to support military treatment facilities, the Defense Health Agency, and other government healthcare systems. Kesimpta is a monoclonal antibody indicated for certain autoimmune neurological conditions, representing the type of specialized pharmaceutical product within the company's extensive federal delivery portfolio. The relatively short completion window indicates this is a routine replenishment order under the established IDC framework, leveraging the existing contract vehicle to meet immediate federal medical supply requirements.
Quick answers
Who was awarded contract SPE2DR26F1W18?
SPE2DR26F1W18 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F1W18 worth?
The government has obligated $36,723 on SPE2DR26F1W18.
Is contract SPE2DR26F1W18 an order under another contract?
Yes. SPE2DR26F1W18 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1W18 competed?
The extent of competition for SPE2DR26F1W18 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award